Stock Fundamentals

Company Information

Company Name
Enliven Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US29337E1029
CIK: 0001672619
CUSIP: 29337E102
Currency: USD
Full Time Employees: 61
Phone: 720 647 8519
Fiscal Year End: December
IPO Date: Mar 12, 2020
Description:

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.

Address:

6200 Lookout Road, Boulder, CO, United States, 80301

Directors & Officers

Name Title Year Born
Mr. Samuel S. Kintz M.B.A. Co-Founder & Head of Pipeline 1986
Mr. Benjamin Hohl CFO & Head of Corporate Development 1989
Dr. Helen Louise Collins M.D. Chief Medical Officer 1963
Dr. Joseph P. Lyssikatos Ph.D. Co-Founder & Research Fellow 1965
Mr. Anish Patel Pharm.D. Co-Founder & COO 1981
Dr. Galya D. Blachman Esq., Ph.D. Chief Legal Officer & Head of Business Development 1977

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 06, 2026 Benjamin Hohl N/A Sale 10.00K $29.58 $295.80K
Feb 17, 2026 Richard A Heyman N/A Sale 1.23K $26.18 $32.20K
Feb 06, 2026 Joseph P Lyssikatos N/A Sale 5.00K $29.04 $145.20K
Jan 20, 2026 Joseph P Lyssikatos N/A Sale 20.00K $26.75 $535.00K
Jan 20, 2026 Richard A Heyman N/A Sale 1.23K $26.75 $32.90K
Jan 09, 2026 Anish Patel N/A Sale 48.30K $27.99 $1.35M
Jan 09, 2026 Joseph P Lyssikatos N/A Sale 91.20K $27.22 $2.48M
Jan 09, 2026 Richard A Heyman N/A Sale 4.29K $25.00 $107.13K
Jan 08, 2026 Joseph P Lyssikatos N/A Sale 41.30K $24.05 $993.31K
Jan 08, 2026 Richard A Heyman N/A Sale 9.64K $25.03 $241.16K
Dec 19, 2025 Joseph P Lyssikatos N/A Sale 5.00K $16.84 $84.20K
Dec 08, 2025 Anish Patel N/A Sale 6.66K $21.02 $140.06K
Nov 19, 2025 Joseph P Lyssikatos N/A Sale 12.50K $22.33 $279.13K
Nov 17, 2025 Samuel Kintz N/A Sale 12.50K $21.82 $272.75K
Nov 07, 2025 Anish Patel N/A Sale 6.67K $17.40 $116.01K
Oct 20, 2025 Joseph P Lyssikatos N/A Sale 12.50K $22.08 $276.00K
Oct 17, 2025 Samuel Kintz N/A Sale 12.50K $21.33 $266.63K
Oct 07, 2025 Anish Patel N/A Sale 6.67K $20.10 $134.01K
Sep 29, 2025 Benjamin Hohl N/A Sale 3.25K $20.40 $66.30K
Sep 26, 2025 Samuel Kintz N/A Sale 3.70K $20.06 $74.22K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Orbimed Advisors, LLC 7.96M Mar 31, 2026 13.07% $6.18 0.00%
FMR Inc 6.83M Mar 31, 2026 11.21% $0.01 -3.92%
Polar Capital Holdings PLC 5.07M Mar 31, 2026 8.32% $0.71 44.18%
BlackRock Inc 3.68M Mar 31, 2026 6.05% $0.00 1.98%
COMMODORE CAPITAL LP 3.28M Mar 31, 2026 5.38% $7.43 -30.21%
Vestal Point Capital LP 3.25M Mar 31, 2026 5.34% $3.56 -15.14%
Vanguard Group Inc 2.80M Dec 31, 2025 4.60% $0.00 9.74%
Bellevue Group AG 2.32M Mar 31, 2026 3.81% $2.17 0.00%
Vanguard Capital Management, LLC 2.17M Mar 31, 2026 3.56% $0.00 0.00%
Fairmount Funds Management LLC 1.86M Mar 31, 2026 3.05% $5.25 -50.00%
Citadel Advisors Llc 1.74M Mar 31, 2026 2.86% $0.01 22.44%
VR Adviser, LLC 1.73M Mar 31, 2026 2.83% $2.53 -46.49%
Novo A/S 1.28M Mar 31, 2026 2.10% $4.07 -13.51%
State Street Corp 1.09M Mar 31, 2026 1.79% $0.00 3.63%
Geode Capital Management, LLC 1.07M Mar 31, 2026 1.75% $0.00 1.69%
Pictet Asset Manangement SA 929.54K Mar 31, 2026 1.53% $0.04 -28.67%
Baker Bros Advisors LP 905.19K Mar 31, 2026 1.49% $0.20 233.52%
Rock Springs Capital Management LP 826.50K Mar 31, 2026 1.36% $1.91 3.52%
Avidity Partners Management LP 800.00K Mar 31, 2026 1.31% $3.44 470.21%
AllianceBernstein L.P. 771.89K Mar 31, 2026 1.27% $0.00 1,995.24%

Shares Statistics

Shares Outstanding: 60.90M
Shares Float: 44.43M
% Insiders: 750.50%
% Institutions: 10,473.70%
Short % Float: 13.55%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Polar Capital Healthcare Opports Inc 2.80M 4.59% ▲ 0.00% Apr 30, 2026
2 Polar Capital Biotech S Inc 2.14M 3.52% ▲ 0.00% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.62M 2.66% ▲ 0.32% Apr 30, 2026
4 Fidelity Select Health Care 1.15M 1.89% ▼ 8.00% Apr 30, 2026
5 Fidelity Small Cap Growth 1.07M 1.76% ▲ 0.00% Mar 31, 2026
6 iShares Russell 2000 ETF 943.53K 1.55% ▲ 0.93% May 29, 2026
7 Pictet-Biotech P USD 754.73K 1.24% ▼ 8.76% Feb 28, 2026
8 Fidelity Stock Selector Small Cap 653.09K 1.07% ▲ 0.00% Mar 31, 2026
9 Fidelity Advisor Health Care I 580.00K 0.95% ▼ 7.64% Apr 30, 2026
10 Fidelity Small Cap Growth K6 569.80K 0.94% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $2.36B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.81B
EBITDA: $-115.59M
Book Value: $7.45
Earnings/Share: $-1.64
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -18.86%
ROE (TTM): -26.64%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 28.66x 0.00x 0.04x N/A 0.00x
2024-12-31 19.99x 0.00x 0.05x N/A 0.00x
2023-12-31 10.28x 0.00x 0.10x N/A 0.00x
2022-12-31 8.00x 0.00x 1.92x -31.87x -0.01x
2021-12-31 19.24x 0.00x 0.06x -266.26x -0.01x
2020-12-31 14.47x 0.00x 0.07x N/A -0.01x
2019-12-31 7.29x 0.00x 0.13x N/A 0.00x
2018-12-31 4.21x 0.00x 0.24x N/A 0.00x
2017-12-31 12.38x 0.00x 0.15x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ELVN.US!